Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{186532,
        author = {Shweta Patil and Abhishek Das},
        title = {Insilico Drug Designing and Molecular Docking Analysis of Novel Drug Analogues Targeting Pde4a Protein in Non-alcoholic Steatohepatitis},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {12},
        number = {no},
        pages = {424-431},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=186532},
        abstract = {The development of therapeutics for Nonalcoholic Steatohepatitis (NASH) is of significant importance due to the disease's rising prevalence. Utilizing bioinformatics databases and tools, this study aimed to design a novel drug by exploring chemical protein interactions and conducting in-silico tests to assess its toxicity and efficacy. Through bioinformatics analysis, Phosphodiesterase 4A (PDE4A) was identified as a crucial target protein involved in NASH. The active site of PDE4A was detected, and a drug analogue was subsequently designed to bind effectively to this site. In-silico toxicity analyses indicated a reduction in active toxic sites from three to one, with the remaining activity related to blood-brain barrier penetration. Molecular docking studies confirmed a strong binding affinity between the drug and the active site of PDE4A, suggesting promising therapeutic potential. These results highlight the effectiveness of using computational approaches in drug design and pave the way for further experimental validation of the analogue drug for treating NASH.},
        keywords = {Drug Design, Molecular Docking, Nonalcoholic Steatohepatitis},
        month = {},
        }